Sources of Bias in Specimens for Research About Molecular Markers for Cancer
- 1 February 2010
- journal article
- research article
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 28 (4), 698-704
- https://doi.org/10.1200/jco.2009.25.6065
Abstract
Claims about the diagnostic or prognostic accuracy of markers often prove disappointing when “discrimination” found between cancers versus normals is due to bias, a systematic difference between compared groups. This article describes a framework to help simplify and organize current problems in marker research by focusing on the role of specimens as a source of bias in observational research and using that focus to address problems and improve reliability. The central idea is that the “fundamental comparison” in research about markers (ie, the comparison done to assess whether a marker discriminates) involves two distinct processes that are “connected” by specimens. If subject selection (first process) creates baseline inequality between groups being compared, then laboratory analysis of specimens (second process) may erroneously find positive results. Although both processes are important, subject selection more fundamentally influences the quality of marker research, because it can hardwire bias into all comparisons in a way that cannot be corrected by any refinement in laboratory analysis. An appreciation of the separateness of these two processes—and placing investigators with appropriate expertise in charge of each—may increase the reliability of research about cancer biomarkers.This publication has 44 references indexed in Scilit:
- Standard Operating Procedures for Serum and Plasma Collection: Early Detection Research Network Consensus Statement Standard Operating Procedure Integration Working GroupJournal of Proteome Research, 2008
- Pivotal Evaluation of the Accuracy of a Biomarker Used for Classification or Prediction: Standards for Study DesignJNCI Journal of the National Cancer Institute, 2008
- Assessment of Serum Proteomics to Detect Large Colon AdenomasCancer Epidemiology, Biomarkers & Prevention, 2008
- Diagnostic Markers for Early Detection of Ovarian CancerClinical Cancer Research, 2008
- Analytical Validation of Serum Proteomic Profiling for Diagnosis of Prostate Cancer: Sources of Sample BiasClinical Chemistry, 2008
- The minimum information about a proteomics experiment (MIAPE)Nature Biotechnology, 2007
- Critical Review of Published Microarray Studies for Cancer Outcome and Guidelines on Statistical Analysis and ReportingJNCI Journal of the National Cancer Institute, 2007
- Microarrays and molecular research: noise discovery?The Lancet, 2005
- A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast CancerThe New England Journal of Medicine, 2004
- DNA Integrity as a Potential Marker for Stool-based Detection of Colorectal CancerClinical Chemistry, 2003